Prednisone Active Not Recruiting Phase 2 Trials for Smith-Magenis Syndrome / Myelodysplastic Syndrome Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01133275Lenalidomide and Prednisone in Low and Int-1 Myelodysplastic Syndrome (MDS) Non 5q MDS